REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lin BioScience, Inc. (Taiwan, China)

Main Activities: Scientific Research and Development Services
Full name: Lin BioScience, Inc. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Lin BioScience, Inc. focuses on developing innovative drugs to treat unmet medical needs. The company was founded in 2016 and is headquartered in Taipei City, Taiwan.

Headquarters
36F, No.68, Sec.5, Zhongxiao E. Rd, Xinyi Dist
Taipei City; Taipei City;

Contact Details: Purchase the Lin BioScience, Inc. report to view the information.

Website: http://www.linbioscience.com

Basic Information
Total Employees:
Purchase the Lin BioScience, Inc. report to view the information.
Outstanding Shares:
Purchase the Lin BioScience, Inc. report to view the information.
Financial Auditors:
Purchase the Lin BioScience, Inc. report to view the information.
Incorporation Date:
May 12, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
9.57%
Purchase this report to view the information.
2.66%
Purchase this report to view the information.
1.1%
Purchase this report to view the information.
0.97%
Purchase this report to view the information.
0.95%
Subsidiaries
Lin Bioscience International Ltd (United Kingdom)
100%
Lin Bioscience Pty Ltd (Australia)
100%
Company Performance
Financial values in the chart are available after Lin BioScience, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-39.43%▼
EBITDA
-41.82%▼
Net Profit (Loss) for the Period
-29.78%▼
Total assets
105%▲
Total equity
115.6%▲
Return on Equity (ROE)
8.88%▲
Quick Ratio
18.85%▲
Cash Ratio
-4.52%▼

Similar companies

Chlitina Holding Limited
 
Syngen Biotech Co., Ltd.
DV Biomed Co., Ltd.
 
CH Biotech R&D Co., Ltd.
Medigen Biotechnology Corporation
 
Norr Offshore Group Ltd
Great Novel Therapeutics Biotech & Medic
 
Steminent Biotherapeutics Inc.
Bio Preventive Medicine Corp.
 
Senhwa Biosciences, Inc.
TWI Biotechnology, Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo